| 0 |
CCR5 Co-receptor Antagonist [EPC] |
1 |
0.0004 |
| 1 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
8 |
0.0004 |
| 2 |
Anticholinergic [EPC] |
5 |
0.0003 |
| 3 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
5 |
0.0002 |
| 4 |
CD30-directed Immunoconjugate [EPC] |
2 |
0.0002 |
| 5 |
Human Immunoglobulin G [EPC] |
4 |
0.0002 |
| 6 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
18 |
0.0002 |
| 7 |
CTLA-4-directed Blocking Antibody [EPC] |
7 |
0.0001 |
| 8 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
1 |
0.0001 |
| 9 |
Cholinergic Muscarinic Antagonist [EPC] |
5 |
0.0001 |
| 10 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
6 |
0.0001 |
| 11 |
Provitamin D2 Compound [EPC] |
3 |
0.0001 |
| 12 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 13 |
Protease Inhibitor [EPC] |
4 |
0.0001 |
| 14 |
Anti-epileptic Agent [EPC] |
18 |
0.0001 |
| 15 |
HER2/neu Receptor Antagonist [EPC] |
6 |
0.0001 |
| 16 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
9 |
0.0001 |
| 17 |
Cytochrome P450 3A Inhibitor [EPC] |
4 |
0.0001 |
| 18 |
Azole Antifungal [EPC] |
10 |
0.0001 |
| 19 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
7 |
0.0001 |
| 20 |
Histamine-1 Receptor Antagonist [EPC] |
5 |
0.0001 |
| 21 |
Central alpha-2 Adrenergic Agonist [EPC] |
3 |
0.0001 |
| 22 |
Mood Stabilizer [EPC] |
12 |
0.0001 |
| 23 |
CD20-directed Cytolytic Antibody [EPC] |
17 |
0.0001 |
| 24 |
Alkylating Drug [EPC] |
13 |
0.0001 |
| 25 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 26 |
Nucleoside Analog Antiviral [EPC] |
4 |
0.0000 |
| 27 |
Benzodiazepine [EPC] |
32 |
0.0000 |
| 28 |
Microtubule Inhibitor [EPC] |
7 |
0.0000 |
| 29 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
4 |
0.0000 |
| 30 |
Topoisomerase Inhibitor [EPC] |
3 |
0.0000 |
| 31 |
Platinum-based Drug [EPC] |
10 |
0.0000 |
| 32 |
Catecholamine [EPC] |
3 |
0.0000 |
| 33 |
Phenothiazine [EPC] |
1 |
0.0000 |
| 34 |
Glycopeptide Antibacterial [EPC] |
2 |
0.0000 |
| 35 |
Tetracycline-class Drug [EPC] |
2 |
0.0000 |
| 36 |
Atypical Antipsychotic [EPC] |
12 |
0.0000 |
| 37 |
General Anesthetic [EPC] |
1 |
0.0000 |
| 38 |
Serotonin-3 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 39 |
Folate Analog Metabolic Inhibitor [EPC] |
8 |
0.0000 |
| 40 |
Corticosteroid [EPC] |
19 |
0.0000 |
| 41 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 42 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 43 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 44 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1 |
0.0000 |
| 45 |
Opioid Agonist [EPC] |
3 |
0.0000 |
| 46 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
2 |
0.0000 |
| 47 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 48 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 49 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 50 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 51 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 52 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
5 |
0.0000 |
| 53 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 54 |
Vitamin D [EPC] |
1 |
0.0000 |
| 55 |
Vitamin B12 [EPC] |
1 |
0.0000 |
| 56 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 57 |
Vitamin C [EPC] |
1 |
0.0000 |
| 58 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 59 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |